We work across a range of life sciences disciplines including clinical development, market access, health economics and outcomes research (HEOR), commercial strategy and operations, pricing and reimbursement, patient services, medical affairs, and therapeutic area-focused initiatives spanning biopharma, specialty pharma, medtech, diagnostics, and emerging life sciences companies. We observe industry trends closely, including navigating how the industry builds closer relationships with patients, evolving commercial strategies and models, deploying services that go beyond medicine or devices, considering how new tools like AI and the cloud can be transformative, and how R&D and the definition of targeted therapy is developing before the world's eyes.